Loading…
JHS Svendgaard Laboratories (JHS)₹8.22+2.24%Personal Care
At the end of the Jun 2026 quarter, JHS Svendgaard Laboratories' shareholders were: promoters 33.89%, FIIs 3.17%, public 62.94%. Promoter holding is unchanged on the quarter. FII holding is up 1.57 percentage points from 1.60% a year earlier. It had 25,154 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 37.77% | 37.77% | 37.77% | 37.77% | 34.60% | 34.60% | 34.60% | 34.60% | 34.60% | 34.60% | 33.89% | 33.89% |
| FIIs | 0.00% | 0.00% | 2.31% | 0.15% | 1.70% | 1.60% | 1.61% | 1.60% | 1.58% | 1.58% | 3.63% | 3.17% |
| DIIs | 0.00% | 9.19% | 6.24% | 6.08% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 62.23% | 53.04% | 53.68% | 56.00% | 63.70% | 63.80% | 63.79% | 63.80% | 63.82% | 63.82% | 62.48% | 62.94% |
| Number of shareholders | 22,797 | 22,651 | 26,452 | 25,772 | 25,998 | 26,280 | 25,571 | 25,159 | 25,011 | 25,155 | 25,334 | 25,154 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Nikhil Nanda | Promoter | 30.29% | 0.00 |
| Sushma Nanda | Promoter | 3.48% | 0.00 |
| Vijay Mohan Govila | Public | 2.76% | 0.00 |
| Puran Associates Private Limited | Public | 2.08% | 0.00 |
| M.B. Finmart Private Limited | Public | 2.07% | 0.00 |
| Coeus Global Opportunities Fund | FII | 2.05% | 0.00 |
| Milky Investment And Trading Company | Public | 2.05% | 0.00 |
| Vic Enterprises Private Limited | Public | 2.05% | 0.00 |
| Bhim Sain Bassi | Public | 1.50% | 0.00 |
| Padma Khandu Solanki | Public | 1.19% | +0.18 |
| Aegis Investment Fund Pcc | FII | 1.09% | −0.45 |
| Harish Chander Nanda | Promoter | 0.02% | New |
| Late Harish Chander Nanda | Promoter | Exited | — |
Promoters held 33.89% of JHS Svendgaard Laboratories at the end of the Jun 2026 quarter, down 0.71 percentage points from 34.60% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 3.17% (down 0.46 percentage points from 3.63% a quarter earlier) and domestic institutions (DIIs) held 0.00% (unchanged at 0.00% a quarter earlier).
JHS Svendgaard Laboratories had 25,154 shareholders at the end of the Jun 2026 quarter, against 25,159 a year earlier.
Vijay Mohan Govila (Public) held 2.76% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.